Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer

Clinical trial NCT03579836 · RECRUITING

Trial details

NCT number: NCT03579836
Sponsor: BeyondBio Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Pancreatic Cancer

Start date: 2018-05-14
Primary completion: 2026-11-30
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.